Invivyd, Inc.

• Invivyd unveils VMS063 candidate at IDWeek for measles therapy
  Traders Union · 21 Oct 2026
• Invivyd presents preclinical data on measles antibody candidate By Investing.com
  Investing.com India · 21 Oct 2026
• Invivyd (IVVD) Stock Today: Drops -7.51%, Key Support at $0.59 2026-10-17 - Spring Pattern
  https://www.siam.in/ · 17 Oct 2026
• Invivyd (IVVD) Slips 6.62% to $0.62 as Shares Press Lower Support - Value Stock Ideas
  https://www.siam.in/ · 16 Oct 2026
• Invivyd starts Phase 2 FLINTLOCK trial of VYD2311 antibody for Long COVID
  Dealroom · 14 Oct 2026
• Invivyd launches phase 2 trial of VYD2311 for long COVID By Investing.com
  Investing.com India · 14 Oct 2026
• Invivyd’s VYD2311 Phase III Study Meets Safety Goals, Eyes FDA Accelerated Approval
  TradingView · 05 Oct 2026
• Invivyd’s pursuit of a Covid vaccine alternative gets a lift, but an FDA hurdle may await
  STAT · 01 Oct 2026
• Ascletis challenges psoriasis field with pill; Invivyd plans Covid filing
  Endpoints News · 29 Sep 2026
• Form 8K Invivyd Inc For: 29 September By Investing.com
  Investing.com India · 29 Sep 2026
• Why Is Invivyd Stock Trading Lower Today? - Invivyd (NASDAQ:IVVD)
  Benzinga · 29 Sep 2026
• Invivyd delays trial data for COVID drug (IVVD:NASDAQ)
  Seeking Alpha · 29 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →